Ubs Group Ag Ice Cure Medical Ltd. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ICCM
# of Institutions
16Shares Held
195KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X026.3KShares$27,1000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$26,3260.0% of portfolio
-
Two Sigma Investments, LP New York, NY18.5KShares$19,0800.0% of portfolio
-
Virtu Financial LLC New York, NY14.6KShares$15,0140.0% of portfolio
-
Hrt Financial LP New York, NY13.5KShares$13,8960.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $37.9M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.